Key Insights

Highlights

Treatment Research

6 treatments under study, led by Lamivudine

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02470650Phase 4Withdrawn

Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV Naive

Showing all 1 trials

Research Network

Common Treatments

  • Lamivudine1
  • Abacavirlamivudine1
  • Elvitegravircobicistatemtricitabinetenofovir1
  • Rilpivirine1
  • Darunavir1

Active Sponsors

  • Juan A. Arnaiz1

Top Investigators

Related Conditions

  • Patient Compliance1

Activity Timeline